bioAffinity Technologies, Inc. Finance Lease, Liability, to be Paid, after Year Five
bioAffinity Technologies, Inc. (BIAF) had Finance Lease, Liability, to be Paid, after Year Five of $197.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive · last filed 2026-08-07
- 2026-06-30: Finance Lease, Liability, to be Paid, after Year Five $197.89K.
- 2026-03-31: Finance Lease, Liability, to be Paid, after Year Five $201.50K.
- 2025-12-31: Finance Lease, Liability, to be Paid, after Year Five $201.50K.
| Period end | Finance Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2026-06-30 | $197.89K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $201.50K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $201.50K 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |